Ibio Net Worth
Ibio Net Worth Breakdown | IBIO |
Ibio Net Worth Analysis
Ibio's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Ibio's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Ibio's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Ibio's net worth analysis. One common approach is to calculate Ibio's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Ibio's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Ibio's net worth. This approach calculates the present value of Ibio's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Ibio's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Ibio's net worth. This involves comparing Ibio's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Ibio's net worth relative to its peers.
To determine if Ibio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Ibio's net worth research are outlined below:
| Ibio Inc is way too risky over 90 days horizon | |
| Ibio Inc appears to be risky and price may revert if volatility continues | |
| Ibio Inc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 225 K. Net Loss for the year was (24.91 M) with profit before overhead, payroll, taxes, and interest of 2.17 M. | |
| Ibio Inc currently holds about 33.52 M in cash with (18.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from MacroaxisInsider: Insider Trading |
Ibio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Ibio Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ibio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Follow Ibio's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.3 M.Market Cap |
|
Project Ibio's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.07) | (1.12) | |
| Return On Capital Employed | (0.67) | (0.70) | |
| Return On Assets | (0.87) | (0.91) | |
| Return On Equity | (1.17) | (1.23) |
When accessing Ibio's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Ibio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Ibio's profitability and make more informed investment decisions.
Evaluate Ibio's management efficiency
Ibio Inc has return on total asset (ROA) of (0.2973) % which means that it has lost $0.2973 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8415) %, meaning that it created substantial loss on money invested by shareholders. Ibio's management efficiency ratios could be used to measure how well Ibio manages its routine affairs as well as how well it operates its assets and liabilities. As of the 27th of November 2024, Return On Tangible Assets is likely to drop to -1.12. In addition to that, Return On Capital Employed is likely to drop to -0.7. At this time, Ibio's Total Assets are very stable compared to the past year. As of the 27th of November 2024, Non Current Assets Total is likely to grow to about 17.9 M, while Other Current Assets are likely to drop about 711.5 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.57 | 5.29 | |
| Tangible Book Value Per Share | 4.16 | 3.96 | |
| Enterprise Value Over EBITDA | 0.15 | 0.15 | |
| Price Book Value Ratio | 0.36 | 0.34 | |
| Enterprise Value Multiple | 0.15 | 0.15 | |
| Price Fair Value | 0.36 | 0.34 | |
| Enterprise Value | -1.8 M | -1.9 M |
The operational strategies employed by Ibio management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Enterprise Value Revenue 93.9123 | Revenue 225 K | Quarterly Revenue Growth (0.88) | Revenue Per Share 0.059 | Return On Equity (0.84) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ibio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ibio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ibio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ibio Corporate Filings
8K | 25th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 10th of October 2024 Other Reports | ViewVerify | |
10K | 24th of September 2024 An amendment to a previously filed Form 10-K | ViewVerify |
Ibio Earnings per Share Projection vs Actual
Ibio Corporate Management
| Lisa Middlebrook | Chief Officer | Profile | |
| Stephen Kilmer | Investor Officer | Profile | |
| Marc JD | General Counsel | Profile | |
| Melissa Berquist | VP Health | Profile | |
| Robert Lutz | Chief Officer | Profile | |
| Dr DVM | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.03) | Revenue Per Share 0.059 | Quarterly Revenue Growth (0.88) | Return On Assets (0.30) | Return On Equity (0.84) |
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.